Clinical Bridging Studies and Modeling Approach for Implementation of a Patient Centric Sampling Technique in Padsevonil Clinical Development.
VAMS
blood
mitra
pharmacokinetics
plasma
Journal
The AAPS journal
ISSN: 1550-7416
Titre abrégé: AAPS J
Pays: United States
ID NLM: 101223209
Informations de publication
Date de publication:
16 11 2023
16 11 2023
Historique:
received:
23
05
2023
accepted:
03
10
2023
medline:
27
11
2023
pubmed:
17
11
2023
entrez:
16
11
2023
Statut:
epublish
Résumé
Volumetric absorptive microsampling (VAMS) techniques have gained popularity these last years as innovative tool for collection of blood pharmacokinetic (PK) samples in clinical trials as they offer many advantages over dried blood spot and conventional venous blood sampling. The use of Mitra
Identifiants
pubmed: 37973662
doi: 10.1208/s12248-023-00866-7
pii: 10.1208/s12248-023-00866-7
doi:
Substances chimiques
padsevonil
0R1HN52K0N
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1Informations de copyright
© 2023. The Author(s).
Références
Muglia P, Hannestad J, Brandt C, DeBruyn S, Germani M, Lacroix B, et al. Padsevonil randomized phase IIa trial in treatment-resistant focal epilepsy: a translational approach. Brain Commun. 2020;2(2):fcaa183. https://doi.org/10.1093/braincomms/fcaa183 .
Wood M, Daniels V, Provins L, Wolff C, Kaminski RM, Gillard M. Pharmacological profile of the novel antiepileptic drug candidate padsevonil: interactions with synaptic vesicle 2 proteins and the GABA(A) receptor. J Pharmacol Exp Ther. 2020;372(1):1–10. https://doi.org/10.1124/jpet.119.261149 .
doi: 10.1124/jpet.119.261149
pubmed: 31619465
Niespodziany I, Ghisdal P, Mullier B, Wood M, Provins L, Kaminski RM, et al. Functional characterization of the antiepileptic drug candidate, padsevonil, on GABA(A) receptors. Epilepsia. 2020;61(5):914–23. https://doi.org/10.1111/epi.16497 .
doi: 10.1111/epi.16497
pubmed: 32297665
pmcid: 7383892
Sigel E, Ernst M. The benzodiazepine binding sites of GABA(A) receptors. Trends Pharmacol Sci. 2018;39(7):659–71. https://doi.org/10.1016/j.tips.2018.03.006 .
doi: 10.1016/j.tips.2018.03.006
pubmed: 29716746
Maass KF, Barfield MD, Ito M, James CA, Kavetska O, Kozinn M, et al. Leveraging patient-centric sampling for clinical drug development and decentralized clinical trials: promise to reality. Clin Transl Sci. 2022;15(12):2785–95. https://doi.org/10.1111/cts.13411 .
doi: 10.1111/cts.13411
pubmed: 36129129
pmcid: 9747123
Baillargeon KR, Mace CR. Microsampling tools for collecting, processing, and storing blood at the point-of-care. Bioeng Transl Med. 2023;8(2): e10476. https://doi.org/10.1002/btm2.10476 .
doi: 10.1002/btm2.10476
pubmed: 36925672
Evans C, Arnold M, Bryan P, Duggan J, James CA, Li W, et al. Implementing dried blood spot sampling for clinical pharmacokinetic determinations: considerations from the IQ Consortium Microsampling Working Group. AAPS J. 2015;17(2):292–300. https://doi.org/10.1208/s12248-014-9695-3 .
doi: 10.1208/s12248-014-9695-3
pubmed: 25488054
Kothare PA, Bateman KP, Dockendorf M, Stone J, Xu Y, Woolf E, et al. An integrated strategy for implementation of dried blood spots in clinical development programs. AAPS J. 2016;18(2):519–27. https://doi.org/10.1208/s12248-015-9860-3 .
doi: 10.1208/s12248-015-9860-3
pubmed: 26857396
pmcid: 4779096
De Kesel PM, Capiau S, Lambert WE, Stove CP. Current strategies for coping with the hematocrit problem in dried blood spot analysis. Bioanalysis. 2014;6(14):1871–4. https://doi.org/10.4155/bio.14.151 .
doi: 10.4155/bio.14.151
pubmed: 25158957
Mano Y, Kita K, Kusano K. Hematocrit-independent recovery is a key for bioanalysis using volumetric absorptive microsampling devices, Mitra. Bioanalysis. 2015;7(15):1821–9. https://doi.org/10.4155/bio.15.111 .
doi: 10.4155/bio.15.111
pubmed: 26295984
Spooner N, Denniff P, Michielsen L, De Vries R, Ji QC, Arnold ME, et al. A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated blood hematocrit. Bioanalysis. 2015;7(6):653–9. https://doi.org/10.4155/bio.14.310 .
doi: 10.4155/bio.14.310
pubmed: 25514576
Sciberras D, Otoul C, Lurquin F, Smeraglia J, Lappert A, De Bruyn S, et al. A pharmacokinetic study of radiprodil oral suspension in healthy adults comparing conventional venous blood sampling with two microsampling techniques. Pharmacol Res Perspect. 2019;7(1): e00459. https://doi.org/10.1002/prp2.459 .
doi: 10.1002/prp2.459
pubmed: 30705758
pmcid: 6349788
Protti M, Mandrioli R, Mercolini L. Tutorial: volumetric absorptive microsampling (VAMS). Anal Chim Acta. 2019;1046:32–47. https://doi.org/10.1016/j.aca.2018.09.004 .
doi: 10.1016/j.aca.2018.09.004
pubmed: 30482302
Kok MGM, Fillet M. Volumetric absorptive microsampling: current advances and applications. J Pharm Biomed Anal. 2018;147:288–96. https://doi.org/10.1016/j.jpba.2017.07.029 .
doi: 10.1016/j.jpba.2017.07.029
pubmed: 28803682
Londhe V, Rajadhyaksha M. Opportunities and obstacles for microsampling techniques in bioanalysis: special focus on DBS and VAMS. J Pharm Biomed Anal. 2020;182: 113102. https://doi.org/10.1016/j.jpba.2020.113102 .
doi: 10.1016/j.jpba.2020.113102
pubmed: 32014628
Li XY, Hu C, Zhu XH, Wang Y, Shu SQ, Luo Z. Pharmacokinetics and safety of padsevonil in healthy Chinese subjects and comparison of two sampling methods for padsevonil quantification. Eur Rev Med Pharmacol Sci. 2023;27(10):4698–707. https://doi.org/10.26355/eurrev_202305_32482 .
doi: 10.26355/eurrev_202305_32482
pubmed: 37259754
EMA (CHMP/EWP/192217/2009 Rev 1 Corr.2). Guideline on bioanalytical method validation 2012. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf
Neupane B, Pandya H, Pandya T, Austin R, Spooner N, Rudge J, et al. Inflammation and cardiovascular status impact midazolam pharmacokinetics in critically ill children: an observational, prospective, controlled study. Pharmacol Res Perspect. 2022;10(5): e01004. https://doi.org/10.1002/prp2.1004 .
doi: 10.1002/prp2.1004
pubmed: 36036654
pmcid: 9422629
Guerra Valero Y, Dorofaeff T, Parker L, Coulthard MG, Sparkes L, Lipman J, et al. Microsampling to support pharmacokinetic clinical studies in pediatrics. Pediatr Res. 2022;91(6):1557–61. https://doi.org/10.1038/s41390-021-01586-4 .
doi: 10.1038/s41390-021-01586-4
pubmed: 34023854
Heinemann L. Finger pricking and pain: a never ending story. J Diabetes Sci Technol. 2008;2(5):919–21. https://doi.org/10.1177/193229680800200526 .
doi: 10.1177/193229680800200526
pubmed: 19885279
pmcid: 2769798
Fruhstorfer H, Schmelzeisen-Redeker G, Weiss T. Capillary blood sampling: relation between lancet diameter, lancing pain and blood volume. Eur J Pain. 1999;3(3):283–6. https://doi.org/10.1053/eujp.1999.0132 .
doi: 10.1053/eujp.1999.0132
pubmed: 10700356
Serafin A, Malinowski M, Prazmowska-Wilanowska A. Blood volume and pain perception during finger prick capillary blood sampling: are all safety lancets equal? Postgrad Med. 2020;132(3):288–95. https://doi.org/10.1080/00325481.2020.1717160 .
doi: 10.1080/00325481.2020.1717160
pubmed: 32027205
Dockendorf MF, Jaworowicz D, Humphrey R, Anderson M, Breidinger S, Ma L, et al. A model-based approach to bridging plasma and dried blood spot concentration data for phase 3 verubecestat trials. AAPS J. 2022;24(3):53. https://doi.org/10.1208/s12248-022-00682-5 .
doi: 10.1208/s12248-022-00682-5
pubmed: 35384522
Roadcap B, Hussain A, Dreyer D, Carter K, Dube N, Xu Y, et al. Clinical application of volumetric absorptive microsampling to the gefapixant development program. Bioanalysis. 2020;12(13):893–904. https://doi.org/10.4155/bio-2020-0074 .
doi: 10.4155/bio-2020-0074
pubmed: 32648772
Iacuzzi V, Posocco B, Zanchetta M, Gagno S, Poetto AS, Guardascione M, et al. Dried blood spot technique applied in therapeutic drug monitoring of anticancer drugs: a review on conversion methods to correlate plasma and dried blood spot concentrations. Pharm Res. 2021;38(5):759–78. https://doi.org/10.1007/s11095-021-03036-6 .
doi: 10.1007/s11095-021-03036-6
pubmed: 33846903
Rowland M, Emmons GT. Use of dried blood spots in drug development: pharmacokinetic considerations. AAPS J. 2010;12(3):290–3. https://doi.org/10.1208/s12248-010-9188-y .
doi: 10.1208/s12248-010-9188-y
pubmed: 20383669
pmcid: 2895450
Merton G, Jones K, Lee M, Johnston A, Holt DW. Accuracy of cyclosporin measurements made in capillary blood samples obtained by skin puncture. Ther Drug Monit. 2000;22(5):594–8. https://doi.org/10.1097/00007691-200010000-00015 .
doi: 10.1097/00007691-200010000-00015
pubmed: 11034266
Chiou WL. The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II). Clin Pharmacokinet. 1989;17(4):275–90. https://doi.org/10.2165/00003088-198917040-00005 .
Remmerie B, De Meulder M, Weiner S, Savitz A. Comparison of capillary and venous drug concentrations after administration of a single dose of risperidone, paliperidone, quetiapine, olanzapine, or aripiprazole. Clin Pharmacol Drug Dev. 2016;5(6):528–37. https://doi.org/10.1002/cpdd.290 .
doi: 10.1002/cpdd.290
pubmed: 27365164
pmcid: 5132056
Mohammed BS, Cameron GA, Cameron L, Hawksworth GH, Helms PJ, McLay JS. Can finger-prick sampling replace venous sampling to determine the pharmacokinetic profile of oral paracetamol? Br J Clin Pharmacol. 2010;70(1):52–6. https://doi.org/10.1111/j.1365-2125.2010.03668.x .
doi: 10.1111/j.1365-2125.2010.03668.x
pubmed: 20642547
pmcid: 2909807
Instiaty I, Lindegardh N, Jittmala P, Hanpithakpong W, Blessborn D, Pukrittayakamee S, et al. Comparison of oseltamivir and oseltamivir carboxylate concentrations in venous plasma, venous blood, and capillary blood in healthy volunteers. Antimicrob Agents Chemother. 2013;57(6):2858–62. https://doi.org/10.1128/AAC.02408-12 .
doi: 10.1128/AAC.02408-12
pubmed: 23507284
pmcid: 3716162
Gordi T, Hai TN, Hoai NM, Thyberg M, Ashton M. Use of saliva and capillary blood samples as substitutes for venous blood sampling in pharmacokinetic investigations of artemisinin. Eur J Clin Pharmacol. 2000;56(8):561–6. https://doi.org/10.1007/s002280000179 .
doi: 10.1007/s002280000179
pubmed: 11151745
Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8(2):135–60. https://doi.org/10.1177/096228029900800204 .
doi: 10.1177/096228029900800204
pubmed: 10501650
Dewitte K, Fierens C, Stockl D, Thienpont LM. Application of the bland–altman plot for interpretation of method-comparison studies: a critical investigation of its practice. Clin Chem. 2002;48(5):799–801. https://doi.org/10.1093/clinchem/48.5.799 .
doi: 10.1093/clinchem/48.5.799
pubmed: 11978620
Schoemaker R, Wade JR, Stockis A. Brivaracetam population pharmacokinetics and exposure-response modeling in adult subjects with partial-onset seizures. J Clin Pharmacol. 2016;56(12):1591–602. https://doi.org/10.1002/jcph.761 .
doi: 10.1002/jcph.761
pubmed: 27146213
Rademacher M, Toledo M, Van Paesschen W, Liow KK, Milanov IG, Esch ML, et al. Efficacy and safety of adjunctive padsevonil in adults with drug-resistant focal epilepsy: results from two double-blind, randomized, placebo-controlled trials. Epilepsia Open. 2022;7(4):758–70. https://doi.org/10.1002/epi4.12656 .
doi: 10.1002/epi4.12656
pubmed: 36176044
pmcid: 9712475